Internal Medicine, Medical Oncology · Houston, TX
NPI
1376070300
Since 2017
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd, Unit 432
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
626 services
Medicare patients, 2024
180
Average age 73
Drug cost, 2024
$2.7M
337 prescriptions
Company payments, 2025
$10K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marcelo V Vailati Negrao was code 99215 (office e&m - established), 379 times for 108 patients. In total Marcelo V Vailati Negrao billed 626 services in 15 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 379 | 108 | $111.30 | $42K |
| 99214 Office E&M - Established | Facility | 94 | 49 | $74.85 | $7,036 |
| 99205 Office E&M - New | Facility | 41 | 41 | $135.66 | $5,562 |
| 99441 Telephone Services | Office | 35 | 20 | $37.74 | $1,321 |
| 99442 Telephone Services | Office | 15 | 14 | $72.08 | $1,081 |
By year: 2022 $69K for 689 services; 2023 $60K for 624 services; 2024 $62K for 626 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marcelo V Vailati Negrao prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 104 prescriptions and refills. In total Marcelo V Vailati Negrao wrote 337 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 104 | 104 | 13 | $1.7M |
| Krazati Adagrasib | 35 | 35 | Under 11 | $664K |
| Ondansetron Hcl Generic | 25 | 25 | 19 | $137 |
| Dexamethasone Generic | 21 | 21 | 15 | $239 |
| Prochlorperazine Maleate Generic | 18 | 18 | Under 11 | $328 |
| Granisetron Hcl Generic | 14 | 14 | Under 11 | $856 |
Brand drugs: 162 claims; generic drugs: 175 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marcelo V Vailati Negrao $10K ($3,537 in general payments such as food, travel and fees and $6,847 for research) from 10 companies. The largest payer was Pfizer Inc. with $8,450.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.